cagrilintide semaglutide cagrisema phase 3 results 2024 2025 Cagrilintide–semaglutide (CagriSema) versus or in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, study REDEFINE 2 CagriSema Trial |

We might suggest starting with 2,000-5,000 mcg injections to help with severe symptoms

Using bacteriostatic water rather than sterile saline extends the stability of the reconstituted solution to approximately 30 days under refrigeration

GHK-Cu appears to promote balanced remodeling, suppressing excessive MMP activity that occurs in chronic wounds and aging skin while supporting appropriate remodeling necessary for wound healing and tissue renewal

5.4 Anti-microbial activity Microbial infections are a challenge, especially with the growth of medication resistance

This rapid clearance might suggest the need for larger doses, yet the peptide initiates cellular processes that continue long after the compound itself has been metabolized

Expected timeline: Similar pattern to topical-only but potentially accelerated and more pronounced results due to enhanced absorption